JENKEM: Application for registration of sodium hyaluronate injection composite solution accepted

JENKEM announced that its wholly-owned subsidiary Tianjin JENKEM Technology Co., Ltd. has submitted a registration application for the sodium hyaluronate injection composite solution independently developed by the company, which has been officially accepted by the Medical Device Technical Review Center of the National Medical Products Administration. The sodium hyaluronate injection composite solution project is a Class III passive implantable medical device independently developed by the company based on polyethylene glycol modification technology, intended for the indication of improving skin dryness and dull complexion in adults. The company will actively promote all work related to the approval of the above project and will fulfill its information disclosure obligations in a timely manner regarding the subsequent approval progress